SynthesisHealth technology assessment (Winchester, England)2025

Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.

Steven J Edwards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.